Technologie medyczne
Firmy argentyńskie działające w jednym sektorze: technologie medyczne
Te Firmy argentyńskie działają w tym samym sektorze, technologie medyczne. Znajdziesz tu ich ceny, zmiany i inne statystyki, które pomogą Ci poznać jak najwięcej szczegółów. Lista zawiera akcje dla dowolnej strategii: giganty o dużej kapitalizacji, takie jak ELI LILLY AND COMPANY CEDEAR EACH 56 REP 1 (USD), spółki o największych zyskach, takie jak ABBOTT LABORATORIES CEDEAR EAC 4 REP 1(USD) i nie tylko. Filtruj listę i w wygodny sposób sprawdzaj wyniki firm.
Symbol | Kapitalizacja rynkowa | Cena | Zmiana % | Wolumen | Realny Wolumen | Cena/Zysk | Zysk na akcję rzeczywisty TTM | Wzrost rzeczywistego zysku na akcję Ostatnie 12 miesięcy r/r | Rentowność dywidend % TTM | Ocena Analityków |
|---|---|---|---|---|---|---|---|---|---|---|
 LLYDELI LILLY AND COMPANY CEDEAR EACH 56 REP 1 (USD)DR | 780,74 T ARS | 14,500 USD | +2,11% | 409 | 0,88 | 112,53 | 124,85 ARS | +178,70% | 0,33% | — |
| LLYELI LILLY AND COMPANY CEDEAR EACH 56 REP 1 DR | 780,74 T ARS | 16 400,000 ARS | +1,71% | 4,96 K | 0,73 | 131,35 | 124,85 ARS | +564,33% | 0,33% | — |
 JNJDJOHNSON & JOHNSON CEDEAR EACH 15 REP 1 ORD SHS(USD)DR | 370,14 T ARS | 9,960 USD | −0,10% | 737 | 0,45 | 29,13 | 352,44 ARS | +130,17% | 1,71% | — |
| JNJJOHNSON & JOHNSON CEDEAR EACH 15 REP 1 ORD SHS DR | 370,14 T ARS | 11 450,000 ARS | −1,51% | 33,5 K | 0,51 | 32,49 | 352,44 ARS | +193,52% | 1,71% | — |
| DJNJ3JOHNSON & JOHNSON CEDEAR(REPR 6.95% BDS) DR | 370,14 T ARS | 1 270,000 ARS | −3,42% | 2 | 0,15 | — | — | — | — | — |
 ABBVDABBVIE INC CEDEAR EA 10 REP 1 COM(USD)DR | 315,12 T ARS | 18,000 USD | +3,75% | 131 | 2,25 | 7,44 | 2 343,37 ARS | +18,73% | 1,77% | — |
| ABBVABBVIE INC CEDEAR EACH 10 REPR 1 COM DR | 315,12 T ARS | 19 900,000 ARS | −1,49% | 843 | 0,75 | 8,49 | 2 343,37 ARS | +183,01% | 1,77% | — |
 MRKDMERCK & CO INC CEDEAR EAC 5 RE 1 (USD)DR | 253,1 T ARS | 19,700 USD | −1,50% | 65 | 0,96 | 21,61 | 883,37 ARS | +319,19% | 1,66% | — |
| MRKMERCK & CO INC CEDEAR (5 REP 1 USD0.50) DR | 253,1 T ARS | 22 500,000 ARS | −1,64% | 12,77 K | 4,81 | 25,47 | 883,37 ARS | +899,22% | 1,66% | — |
 TMOTHERMO FISHER SCIENTIFIC INC CEDEAR EACH 22 REP 1DR | 230,23 T ARS | 30 750,000 ARS | −0,16% | 55 | 0,14 | 55,01 | 558,94 ARS | +251,94% | 0,14% | — |
 ABTDABBOTT LABORATORIES CEDEAR EAC 4 REP 1(USD)DR | 227,08 T ARS | 32,500 USD | +4,84% | 58 | 2,97 | 18,10 | 1 850,70 ARS | +490,19% | 0,85% | — |
| ABTABBOTT LABORATORIES CEDEAR EACH 4 REP 1 DR | 227,08 T ARS | 36 600,000 ARS | +1,04% | 474 | 0,33 | 19,78 | 1 850,70 ARS | +652,64% | 0,85% | — |
 AZNDASTRAZENECA PLC CEDEAR EA RE 0.5 ADR (USD)DR | 221,55 T ARS | 34,950 USD | +1,16% | 4 | 0,15 | 49,96 | 677,80 ARS | +64,44% | 1,42% | — |
| AZNASTRAZENECA PLC CEDEAR EACH REP 0.5 ADR USD0.25 DR | 221,55 T ARS | 40 400,000 ARS | −0,37% | 2,18 K | 2,84 | 59,60 | 677,80 ARS | +291,99% | 1,42% | — |
 ISRGINTUITIVE SURGICAL INC CEDEAR EACH 90 REP 1 ORDDR | 217,83 T ARS | 7 680,000 ARS | −6,57% | 518 | 1,65 | 117,24 | 65,51 ARS | +275,06% | 0,00% | — |
 NVSDNOVARTIS AG CEDEAR EAC 4 REP 1(USD)DR | 206,17 T ARS | 25,300 USD | −0,39% | 1 | 0,31 | 2,83 | 8 672,72 ARS | +140,89% | 3,66% | — |
| NVSNOVARTIS AG CEDEAR EACH 4 REP 1 DR | 206,17 T ARS | 29 300,000 ARS | −1,18% | 47 | 0,22 | 3,38 | 8 672,72 ARS | +474,20% | 3,66% | — |
 DHRDANAHER CORP CEDEAR EACH 54 REP 1 ORDDR | 185,9 T ARS | 5 320,000 ARS | −0,56% | 304 | 0,92 | 72,12 | 73,76 ARS | +137,74% | 0,19% | — |
 AMGNDAMGEN INC CEDEAR EACH 30REPR 1 ORD USD0.0001 (USD)DR | 155,02 T ARS | 9,300 USD | +1,09% | 5 | 0,10 | 36,18 | 249,09 ARS | −50,42% | 2,28% | — |
| AMGNAMGEN INC CEDEAR EACH 30 REP 1 DR | 155,02 T ARS | 10 725,000 ARS | −1,38% | 2,67 K | 0,61 | 43,06 | 249,09 ARS | +18,17% | 2,28% | — |
 PFEDPFIZER INC CEDEAR 4 REP 1 ORD USD0.05(USD)DR | 154,82 T ARS | 6,620 USD | −1,49% | 1,25 K | 0,57 | 27,33 | 234,71 ARS | +35,96% | 3,24% | — |
| PFEPFIZER INC CEDEAR EACH 4 REP 1 ORD USD0.05 DR | 154,82 T ARS | 7 640,000 ARS | −2,55% | 11,47 K | 0,43 | 32,55 | 234,71 ARS | +224,10% | 3,24% | — |
 BMYDBRISTOL-MYERS SQUIBB CO CEDEAR EACH 3 REP 1 USDDR | 126,72 T ARS | 20,300 USD | +4,10% | 5 | 0,53 | — | −1 078,84 ARS | −253,68% | 1,98% | — |
| BMYBRISTOL-MYERS SQUIBB CO CEDEAR EACH 3 REP 1 DR | 126,72 T ARS | 23 325,000 ARS | −0,32% | 2,32 K | 4,90 | — | −1 078,84 ARS | −466,33% | 1,98% | — |
 GILDDGILEAD SCIENCES INC CEDEAR EACH 4 REP 1 SHS (USD)DR | 121,46 T ARS | 24,500 USD | +0,41% | 2 | 0,29 | — | −50,65 ARS | −107,71% | 1,67% | — |
| GILDGILEAD SCIENCES INC CEDEAR EACH 4 REP 1 COM USD0.001 DR | 121,46 T ARS | 27 225,000 ARS | −0,91% | 29 | 0,07 | — | −50,65 ARS | −118,38% | 1,67% | — |
 MDTMEDTRONIC PLC CEDEAR EACH 4 REP 1DR | 121,1 T ARS | 26 350,000 ARS | −0,28% | 357 | 0,53 | 39,18 | 672,48 ARS | +274,72% | 1,87% | — |
 GSKDGSK PLC CEDEAR EACH REPR 1/4 ADR (USD)DR | 71,58 T ARS | 8,580 USD | −3,38% | 20 | 0,25 | 27,01 | 307,84 ARS | −37,30% | 3,15% | — |
| GSKGSK PLC CEDEAR EACH REPR 1/4 ADR DR | 71,58 T ARS | 10 025,000 ARS | −0,74% | 745 | 1,22 | 32,57 | 307,84 ARS | +49,45% | 3,15% | — |
 PHGKONINKLIJKE PHILIPS NV CEDEAR EACH REPR 1/5 ADRDR | 26,05 T ARS | 6 320,000 ARS | −0,16% | 470 | 0,29 | — | −689,04 ARS | −3,81% | 0,00% | — |
 BIIBDBIOGEN INC CEDEAR EAC 13 RE 1 COM(USD)DR | 22,31 T ARS | 11,600 USD | +0,43% | 40 | 3,51 | 16,16 | 695,64 ARS | +96,62% | 0,00% | — |
| BIIBBIOGEN INC CEDEAR EACH 13 REP 1 COM USD0.0005 DR | 22,31 T ARS | 13 075,000 ARS | +0,19% | 479 | 0,74 | 18,80 | 695,64 ARS | +368,68% | 0,00% | — |
 MRNADMODERNA INC CEDEAR EACH 19 REP 1 ORD (USD)DR | 16,69 T ARS | 2,230 USD | +0,90% | 242 | 0,99 | — | −262,17 ARS | +31,39% | 0,00% | — |
| MRNAMODERNA INC CEDEAR EACH 19 REP 1 ORD DR | 16,69 T ARS | 2 525,000 ARS | −2,13% | 80,98 K | 1,14 | — | −262,17 ARS | −63,54% | 0,00% | — |
 RICHLABORATORIOS RICHMOND SACIF | 138,89 B ARS | 1 720,000 ARS | 0,00% | 2,15 K | 0,19 | 17,86 | 96,29 ARS | — | 0,00% | — |
 ROSEINSTITUTO ROSENBUCH SA DE BIOLOGIA | 4,6 B ARS | 108,000 ARS | 0,00% | 11,95 K | 3,24 | 25,30 | 4,27 ARS | +64,50% | 0,00% | — |